Com­pound­ing as­so­ci­a­tion to ask for clar­i­ty around tirzepatide's short­age sta­tus

The Al­liance for Phar­ma­cy Com­pound­ing (APC) wants clar­i­ty around the FDA’s de­ci­sion to re­con­sid­er tirzepatide’s re­moval from its na­tion­al short­age list.

Com­pounders are al­lowed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER